Evidence map›Paper›PMID 28892071›Full record

ArticleTranslational psychiatry2017

A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility.

H Kimura, Y Fujita, T Kawabata, K Ishizuka, C Wang, Y Iwayama, Y Okahisa, I Kushima, M Morikawa, Y Uno and 10 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Probing theFrontiers in neuroscience · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Molecular genetics of 22q11.2 deletion syndrome.American journal of medical genetics. Part A · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

H KimuraDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Y FujitaDepartment of Molecular Neuroscience, Osaka University Graduate School of Medicine, Osaka, Japan.
T KawabataLaboratory of Protein Informatics Institute for Protein Research, Osaka University Graduate School of Medicine, Osaka, Japan.
K IshizukaDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
C WangDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Y IwayamaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama, Japan.
Y OkahisaDepartment of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
I KushimaDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
M MorikawaDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Y UnoDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
T OkadaDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
M IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
T InadaDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
A BrankoDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0001-8982-4580
D MoriDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
T YoshikawaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama, Japan.
N IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
H NakamuraLaboratory of Protein Informatics Institute for Protein Research, Osaka University Graduate School of Medicine, Osaka, Japan.
T YamashitaDepartment of Molecular Neuroscience, Osaka University Graduate School of Medicine, Osaka, Japan.
N OzakiDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-7360-4898
Nagoya University · JPFujita Health University · JPProtein Research Foundation · JPRIKEN Center for Brain Science · JPThe University of Osaka · JPMcLean Hospital · USOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reticulon 4 receptor (RTN4R) plays an essential role in regulating axonal regeneration and plasticity in the central nervous system through the activation of rho kinase, and is located within chromosome 22q11.2, a region that is known to be a hotspot for schizophrenia (SCZ) and autism spectrum disorder (ASD). Recently, rare variants such as copy-number variants and single-nucleotide variants have been a focus of research because of their large effect size associated with increased susceptibility to SCZ and ASD and the possibility of elucidating the pathophysiology of mental disorder through functional analysis of the discovered rare variants. To discover rare variants with large effect size and to evaluate their role in the etiopathophysiology of SCZ and ASD, we sequenced the RTN4R coding exons with a sample comprising 370 SCZ and 192 ASD patients, and association analysis using a large number of unrelated individuals (1716 SCZ, 382 ASD and 4009 controls). Through this mutation screening, we discovered four rare (minor allele frequency <1%) missense mutations (R68H, D259N, R292H and V363M) of RTN4R. Among these discovered rare mutations, R292H was found to be significantly associated with SCZ (P=0.048). Furthermore, in vitro functional assays showed that the R292H mutation affected the formation of growth cones. This study strengthens the evidence for association between rare variants within RTN4R and SCZ, and may shed light on the molecular mechanisms underlying the neurodevelopmental disorder.

Indexed as

AdolescentAdultAutism Spectrum DisorderChildExonsFemaleGene FrequencyGrowth ConesHumansMaleMiddle AgedMutationMutation, MissenseNogo Receptor 1Polymorphism, Single Nucleotiderho-Associated KinasesNogo Receptor 1rho-Associated Kinases

Identifiers

PMID28892071
PMCPMC5611737
OpenAlexW2747191277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.